市场调查报告书
商品编码
1559457
颅颜面固定 (CMF) 装置 - 市场回顾、竞争格局、市场预测 (2030)Cranio Maxillofacial Fixation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
2023年全球颅颜固定 (CMF) 设备市场规模预估为17.6亿美元,预计2030年将达到23.6亿美元,估计2024年至2030年将成长。为5.05%。由于机动车事故和运动导致的脑外伤发病率高、上颚骨骨折的发生率很高、脸部创伤病例的复杂性不断增加,以及定制植入物的3D 列印等先进技术的集成,预计到2024年该市场将成长。
颅颜面固定 (CMF) 设备的市场动态
根据国际脑损伤协会 (2024年) 的资料,欧盟 (EU) 每年约有 100万人因脑损伤住院。其中,机车事故占创伤性脑损伤 (TBI) 的50%。此外,与运动相关的脑损伤也对这一数字做出了重大贡献,估计每年有 30万人受伤。冬季运动,特别是滑雪和滑冰,与大约20,000 例脑损伤有关。因此,机动车辆事故和体育相关活动造成的脑损伤的高发生率增加了对有效治疗解决方案的需求,增加了对颅颜固定 (CMF) 设备来解决这些损伤的需求。
根据美国国立卫生研究院 (2023) 的资料,运动伤害在上颚骨骨折中占很大一部分,范围从 6%到 33%。纽西兰一项针对 25,000名脸部骨折患者的研究发现,63.5%的患者出现中颜面骨折,而只有 3.3%的患者出现上颜面骨折。根据2019年的资料,对 93名脸部外伤患者进行回顾,56.9%的病例眶下孔受到影响,86%的病例观察到眶底移位。因此,运动伤害导致的上颚骨骨折的流行、颜面中部的严重受累以及眶下孔和眼眶底移位的高发生率强烈表明了对颅颜面固定 (CMF) 装置的需求。
此外,用于开发定制患者专用植入物的3D 列印等先进技术的整合以及目标人群的高度偏好也将推动颅颌面固定 (CMF) 设备市场的成长。例如,2021年7月,Lucid Implants 在印度宣布,将利用先进的3D 列印技术和虚拟手术规划,根据患者独特的脸部解剖结构製造基于聚醚醚酮 (PEEK) 的客製化植入物,这是第一家这样做的公司。
因此,在2024年至2030年的预测期内,上述所有因素预计将相互作用,推动颅颜固定 (CMF) 设备市场的发展。
然而,植入物的机械故障,包括弯曲、鬆动和断裂,以及由于压力和血肿导致的暂时或慢性神经损伤,可能会抑制颅颜面固定 (CMF) 设备市场的成长。颅颜面固定 (CMF) 设备细分市场分析
在颅颜面固定 (CMF) 设备市场的应用领域,神经外科类别预计将在2023年占据最大的市场收入占有率。这一类别的快速成长可归因于神经系统疾病和创伤性脑损伤的日益流行,这些疾病和脑外伤经常需要复杂的颅骨修復和重建。神经外科手术通常包括对颅颜结构的复杂且关键的干预,需要使用固定装置来确保稳定和准确的结果。
神经外科技术和技术的进步,例如增强成像和微创方法,促进该细分市场的成长。这些设备在为接受神经外科手术的患者提供结构支撑和促进最佳復健方面发挥着重要作用。随着神经外科的不断发展和扩展,对高品质 CMF 固定解决方案的依赖预计将进一步增加其收入占有率。
因此,由于上述所有因素,预计神经外科类别将在2024-2030年预测期内表现出可观的成长,并最终促进整个颅颜固定 (CMF) 设备市场的成长。本报告研究和分析了全球颅颚面固定 (CMF) 设备市场,提供了每个地区的市场规模和预测、过去三年的产品/技术发展以及每个细分市场的业绩和前景等资讯. .
Cranio Maxillofacial Fixation (CMF) Devices Market by Product Type (CMF Plate And Screw Fixation Devices, Cranial Flap Fixation Devices, CMF Distraction Devices, Temporomandibular Joint Replacement Devices, and Bone Graft Substitute), Material (Metals & Alloys, Bioabsorbable, Ceramics, and Others), Application (Neurosurgery, Orthognathic Surgery, Plastic Surgery, and Others), End-User (Hospitals, Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing incidence of traumatic brain injuries, facial fractures, and the rising research and product development activities across the globe
The cranio maxillofacial fixation devices market was valued at USD 1.76 billion in 2023, growing at a CAGR of 5.05% during the forecast period from 2024 to 2030 to reach USD 2.36 billion by 2030. The cranio maxillofacial fixation devices market is experiencing significant growth owing to the high incidence of traumatic brain injuries from motor vehicle accidents, and sports, the considerable prevalence of maxillary fractures, and the increasing complexity of facial trauma cases, the integration of advanced technologies like 3D printing for customized implants, among others which is expected to drive the cranio maxillofacial fixation devices market during the forecast period from 2024 to 2030.
Cranio Maxillofacial Fixation (CMF) Devices Market Dynamics:
According to International Brain Injury Association (2024), brain injuries result in approximately one million hospital admissions annually within the European Union. Among these, motor vehicle crashes are responsible for 50% of traumatic brain injuries (TBIs). Additionally, sports-related brain injuries contribute significantly to this figure, with an estimated 300,000 injuries occurring each year. Winter sports, particularly skiing and ice-skating, are linked to around 20,000 of these brain injuries. Thus high incidence of brain injuries from motor vehicle crashes and sports-related activities underscores a growing need for effective treatment solutions, highlighting the demand for cranio maxillofacial fixation (CMF) devices to address these injuries.
According to data from the National Institute of Health (2023), sporting injuries account for a significant portion of maxillary fractures, ranging from 6% to 33%. A study in New Zealand of 25,000 patients with facial fractures found that a substantial portion involved the midface, at 63.5%, while only 3.3% involved the upper third of the face. A review of 93 patients with facial trauma revealed that the infraorbital foramen was affected in 56.9% of cases, and displacement of the orbital floor was present in 86% of cases based on data from 2019. Thus, the prevalence of maxillary fractures due to sporting injuries, the significant involvement of the midface, and the high rates of infraorbital foramen and orbital floor displacement highlight the demand for Cranio Maxillofacial Fixation (CMF) devices.
Furthermore, integrating advanced technology such as 3-D printing for developing customized and patient-specific implants and their high preference among the target population is also projected to grow the cranio maxillofacial fixation devices market. For instance, in July 2021, Lucid Implants became the first Indian company to produce Polyether ether ketone (PEEK) based customized implants keeping patients' unique facial anatomy in mind with advanced 3D printing technologies and virtual surgical planning.
Hence, the interplay of all the above mentioned factors are expected to drive the market of cranio maxillofacial fixation (CMF) devices market during the given forecast period from 2024 to 2030.
However, mechanical failure of the implant, including bending, loosening or breakage and temporary or chronic neural damage resulting from pressure or hematomata may restrain the growth of the cranio maxillofacial fixation (CMF) devices market.
Cranio Maxillofacial Fixation (CMF) Devices Market Segment Analysis:
Cranio Maxillofacial Fixation (CMF) Devices Market by Product Type (CMF Plate And Screw Fixation Devices, Cranial Flap Fixation Devices, CMF Distraction Devices, Temporomandibular Joint Replacement Devices, and Bone Graft Substitute), Material (Metals & Alloys, Bioabsorbable, Ceramics, and Others), Application (Neurosurgery, Orthognathic Surgery, Plastic Surgery, and Others), End-User (Hospitals, Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the application segment of cranio maxillofacial fixation (CMF) device market, the neurosurgery category is predicted to account for the largest market revenue share in 2023. The rapid growth of this category can be attributed due the increasing prevalence of neurological disorders and traumatic brain injuries, which frequently require complex cranial repairs and reconstructions. Neurosurgical procedures often involve intricate and critical interventions on the craniofacial structure, necessitating the use of fixation devices to ensure stable and precise outcomes.
The advancements in neurosurgical techniques and technology, including enhanced imaging and minimally invasive approaches, have contributed to the growth of this segment. These devices play a crucial role in providing structural support and facilitating optimal recovery in neurosurgical patients. As neurosurgery continues to evolve and expand, the reliance on high-quality CMF fixation solutions is expected to further bolster its revenue share.
Therefore, due to all the aforementioned factors, the neurosurgery category is likely to witness considerable growth, eventually contributing to growth of the overall cranio maxillofacial fixation (CMF) device market during the forecast period from 2024 to 2030.
North America is expected to dominate the overall cranio maxillofacial fixation (CMF) device market:
Among all the regions, North America is expected to amass the largest share of the cranio maxillofacial fixation (CMF) devices market. This can be ascribed to the rising incidence of facial cosmetic procedures and traumatic brain injuries, advancements in product development & regulatory approvals, and the significant contributions of key market players in the region. The combination of these factors is expected to drive the continued expansion and innovation in the cranio maxillofacial fixation (CMF) device market from 2024 to 2030.
As per data from the American Society of Plastic Surgeons for 2024, there were 1,575,244 facial cosmetic surgery procedures performed in the United States in 2023. This represents a notable increase from the 1,498,361 procedures conducted in 2022, reflecting a growth rate of approximately 5%. This upward trend highlights the growing demand for facial cosmetic procedures, underscoring the expanding market of cranio maxillofacial fixation (CMF) device.
According to the data provided by the Centre for Disease Control and Prevention (2024), in 2021, there were more than 586 traumatic brain injury-related hospitalizations per day in the US. Traumatic brain injuries, caused by head trauma from accidents, falls, or sports injuries, require prompt and accurate diagnosis to assess the extent of brain damage and guide treatment decisions. These conditions often lead to fractures that require surgical intervention and stabilization to ensure proper healing.
Increasing product developmental activities by the regulatory body like product clearances in the region also pushes forward the revenue share of these devices. For instance, in December 2023, RevBio, Inc. announced approval from the U.S. Food and Drug Administration to initiate a pilot clinical trial involving 20 patients. This trial will evaluate the safety and efficacy of TETRANITE, the company's innovative bone adhesive biomaterial, for the immediate stabilization and fixation of cranial flaps following craniotomy procedures related to brain surgery.
The presence of key market players in the region is significantly bolstering the market for Cranio Maxillofacial Fixation (CMF) devices. Major companies like Stryker, Zimmer Biomet, and Medtronic have established strong footholds in the region, driving innovation and market growth. For example Zimmer Biomet's commitment to developing cutting-edge CMF devices, such as their comprehensive range of fixation plates and screws, has further strengthened their market position. The extensive research and development activities, combined with a robust distribution network, enable these players to deliver high-quality, technologically advanced products to a wide end-user base.
Thus, all the factors mentioned above promote a conducive environment for the cranio maxillofacial fixation (CMF) devices market during the forecast period from 2024 to 2030.
Cranio Maxillofacial Fixation (CMF) Devices Market key players:
Some of the key market players operating in the cranio maxillofacial fixation devices market include Zimmer Biomet, Stryker Corporation, Medtronic, Johnson & Johnson Services, Inc, Advin Health Care, LUCID Implants, Auxein Medical, KLS Martin Group, Medartis AG, Integra LifeSciences, Aesculap, Inc, OsteoMed, Inion, JEIL MEDICAL CORPORATION, and others.
Recent Developmental Activities in the Cranio Maxillofacial Fixation (CMF) Devices Market:
Key Takeaways from the Cranio Maxillofacial Fixation (CMF) Devices Market Report Study
Target audience who can be benefited from this Cranio Maxillofacial Fixation (CMF) Devices Market Report Study
Frequently Asked Questions for the Cranio Maxillofacial Fixation (CMF) Devices Market:
Cranio maxillofacial fixation (CMF) devices are used to rectify the facial deformity or skull fracture to restore proper function. The CMF devices include plate and screw systems, distractors, bone grafts, and others.
The cranio maxillofacial fixation devices market was valued at USD 1.76 billion in 2023, growing at a CAGR of 5.05% during the forecast period from 2024 to 2030 to reach USD 2.36 billion by 2030.
The cranio maxillofacial fixation devices market is experiencing significant growth owing to the high incidence of traumatic brain injuries from motor vehicle accidents and sports, the significant prevalence of maxillary fractures, and the increasing complexity of facial trauma cases, the integration of advanced technologies like 3D printing for customized implants further supports this growth, and among others which is expected to drive the cranio maxillofacial fixation devices market during the forecast period from 2024 to 2030.
Some of the key market players operating in the cranio maxillofacial fixation devices market include Zimmer Biomet, Stryker Corporation, Medtronic, Johnson & Johnson Services, Inc, Advin Health Care, LUCID Implants, Auxein Medical, KLS Martin Group, Medartis AG, Integra LifeSciences, Aesculap, Inc, OsteoMed, Inion, JEIL MEDICAL CORPORATION, and others.
Among all the regions, North America is estimated to hold a significant revenue share in the cranio maxillofacial fixation devices market. This can be ascribed to the rising incidence of facial cosmetic procedures and traumatic brain injuries, advancements in product development & regulatory approvals, and the significant contributions of key market players in the region. The combination of these factors is expected to drive the continued expansion and innovation in the cranio maxillofacial fixation (CMF) device market from 2024 to 2030.